Opinion statement
Glial neoplasms in children comprise many heterogeneous tumors that include pilocytic and fibrillary astrocytomas, ependymomas, and the diffuse intrinsic pontine gliomas. In contrast to adults, most of whom present with high-grade fibrillary neoplasms, alternate histologies represent most cases seen in the pediatric setting. In addition, although most adult gliomas are supratentorial in location, in pediatrics infratentorial tumors (posterior fossa and brain stem) predominate. We discuss three specific tumors: diffuse intrinsic pontine gliomas; pilocytic astrocytomas; and ependymomas. Maximal surgical resection is the mainstay of therapy for both pilocytic astrocytomas and ependymomas. Failure to achieve an optimal resection often results in progression and the need for further therapy for patients with pilocytic astrocytomas, and is ultimately fatal in most children with subtotally resected ependymomas. Surgical resection has no role in the treatment of pontine gliomas. Focal radiation therapy is included routinely in the treatment of ependymomas, and it has been shown to improve event-free survival. This therapy also is used in the treatment of pontine gliomas because radiation treatment appears to slow inevitable tumor progression. Radiation therapy in pilocytic astrocytomas is generally reserved for patients who progress after an initial surgical resection or for those patients with midline tumors; these patients are poor candidates for aggressive surgical resection. The role of chemotherapy in these tumors is in evolution. Chemotherapy for pilocytic astrocytomas, particularly in young children (for whom radiation therapy is avoided), appears to be effective in the treatment of a subset of patients. Up-front chemotherapy is generally reserved for the youngest children who present with ependymoma. In the recurrence setting, chemotherapy has shown some activity, although this approach is never curative. Despite the application of various chemotherapeutics and other biologic agents, none of these therapies has improved the prognosis for patients with the uniformly lethal pontine glioma.
Similar content being viewed by others
References and Recommended Reading
Pollack IF: Brain tumors in children [see comments]. New Engl J Med 1994, 331:1500–1507. An excellent review on the topic of brain tumors in children.
Broniscer A, Gajjar A, Bhargava R, et al.: Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997, 40:331–338.
Molloy PT, Bilaniuk LT, Vaughan SN, et al.: Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 1995, 45:1897–1902.
Gajjar A, Sanford RA, Heideman R, et al.: Low-grade astrocytoma: a decade of experience at St. Jude Children’s Research Hospital. J Clin Oncol 1997, 15:2792–2799. A comprehensive analysis of the St. Jude’s experience with presentation, treatment, and outcome of patients with low-grade gliomas.
Applegate GL, Marymont MH: Intracranial ependymomas: a review. Cancer Invest 1998, 16:588–593.
Duffner PK, Krischer JP, Sanford RA, et al.: Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 1998, 28:215–222.
Bowers DC, Georgiades C, Aronson LJ, et al.: Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg 2000, 32:24–29.
Albright AL, Packer RJ, Zimmerman R, et al.: Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 1993, 33:1026–1030.
Pollack IF, Claassen D, al-Shboul Q, et al.: Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 1995, 82:536–547.
Wisoff JH, Abbott R, Epstein F: Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 1990, 73:661–667.
Sutton LN, Molloy PT, Sernyak H, et al.: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995, 83:583–589.
Robertson PL, Zeltzer PM, Boyett JM, et al.: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children’s Cancer Group. J Neurosurg 1998, 88:695–703. An analysis of 32 patients with ependymoma treated on a single cooperative group trial with an analysis of prognostic factors and outcome.
Hukin J, Epstein F, Lefton D, Allen J: Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 1998, 29:40–45.
Palma L, Celli P, Mariottini A, et al.: The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv Syst 2000, 16:170–175.
Freeman CR, Krischer JP, Sanford RA, et al.: Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 1993, 27:197–206.
Packer RJ, Zimmerman RA, Kaplan A, et al.: Early cystic/ necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas. Data from the Childrens Cancer Group. Cancer 1993, 71:2666–2674.
Mandell LR, Kadota R, Freeman C, et al.: There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy [see comments]. Int J Radiat Oncol Biol Phys 1999, 43:959–964.
Karim AB, Maat B, Hatlevoll R, et al.: A randomized trial on dose-response in radiation therapy of lowgrade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996, 36:549–556.
Hodgson DC, Goumnerova LC, Loeffler JS, et al.: Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 2001, 50:929–935.
Kida Y, Kobayashi T, Mori Y: Gamma knife radiosurgery for low-grade astrocytomas: results of long-term follow up. J Neurosurg 2000, 93(suppl)3:42–46.
Mork SJ, Loken AC: Ependymoma: a follow-up study of 101 cases. Cancer 1977, 40:907–915.
Kovnar E, Kun L, Burger P, Krishner J: Patterns of dissemination and recurrence in childhood ependymoma: Preliminary results of Pediatric Oncology Group Protocol #8532. Ann Neurol 1991, 30:457.
Rousseau P, Habrand JL, Sarrazin D, et al.: Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 1994, 28:381–386.
Carrie C, Mottolese C, Bouffet E, et al.: Non-metastatic childhood ependymomas. Radiother Oncol 1995, 36:101–106.
Janss AJ, Grundy R, Cnaan A, et al.: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995, 75:1051–1059.
Packer RJ, Sutton LN, Bilaniuk LT, et al.: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 1988, 23:79–85.
Packer RJ, Ater J, Allen J, et al.: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997, 86:747–754. This study documents the effectiveness of chemotherapy in the treatment of low-grade gliomas, particularly in the youngest children.
Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL: Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediatr Oncol 1996, 27:8–14.
White L, Kellie S, Gray E, et al.: Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children’s Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol 1998, 20:125–130.
Foreman NK, Love S, Gill SS, Coakham HB: Secondlook surgery for incompletely resected fourth ventricle ependymomas: technical case report. Neurosurgery 1997, 40:856–860.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen, K.J., Broniscer, A. & Glod, J. Pediatric glial tumors. Curr. Treat. Options in Oncol. 2, 529–536 (2001). https://doi.org/10.1007/s11864-001-0074-9
Issue Date:
DOI: https://doi.org/10.1007/s11864-001-0074-9